Exosomes from stem cells for active ulcerative colitis
Part of Digestive system clinical trials.
This trial tests whether exosomes (tiny particles) from human umbilical cord stem cells can help treat active ulcerative colitis. It is for people who have not responded well to standard treatments or cannot tolerate them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had ulcerative colitis for at least 3 months, confirmed by a doctor and a colonoscopy.
- Your disease is currently active, with a Mayo score between 6 and 12.
- You are between 18 and 75 years old and weigh at least 40 kg (about 88 lbs).
- You have tried and not responded to, or cannot tolerate, certain standard treatments like steroids, immune modulators, or advanced therapies.
- You are not currently hospitalized for UC, do not have a severe infection, and have no history of cancer in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called HSK47388 for people with moderate to severe ulcerative colitis who have not had good results from other treatments. The goal is to see if it can reduce inflammation and improve symptoms.
This study tests whether a new drug called Hemay005 can help people with moderate to severe ulcerative colitis (a chronic bowel condition causing inflammation and symptoms like diarrhea and abdominal pain) who haven't responded well to or can't tolerate standard treatments. The goal is to reduce inflammation and improve symptoms.
This study tests a new drug called XmAb942 for people with moderate to severe ulcerative colitis. It aims to see if the drug can reduce inflammation and improve symptoms when other treatments haven't worked well enough or caused side effects.
This study tests an experimental tablet for people with moderate to severe ulcerative colitis that hasn't improved with standard treatments. It aims to see if the tablet can reduce symptoms and inflammation.
This trial tests whether exosomes from milk can help adults with ulcerative colitis. Exosomes are tiny particles that may reduce inflammation in the colon.
This trial tests a new treatment using your own immune cells (called CAR-T cells) to calm down the immune attack that causes ulcerative colitis. It is for people with moderate to severe colitis who have not gotten better with standard medicines.
Hear when a new Ulcerative Colitis (UC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.